芯能科技：10月24日召开董事会会议

Group 1 - The core point of the article is that Xinneng Technology (SH 603105) held its 12th meeting of the 5th board of directors on October 24, 2025, to discuss the revision of the "Major Internal Reporting System" [1] - For the year 2024, Xinneng Technology's revenue composition is as follows: photovoltaic industry accounts for 98.46%, energy storage industry accounts for 0.73%, other businesses account for 0.62%, and charging pile industry accounts for 0.19% [1] - As of the report date, Xinneng Technology has a market capitalization of 4.6 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year, highlighting the hot secondary market for biomedicine [1] - A dialogue with Lu Gang, a partner at Chuangdong Investment, indicates that while the secondary market is thriving, the primary market is facing challenges in fundraising [1]